Inventor

KALDOR STEPHEN W

US92 patents

⚠️ This page may combine multiple inventors who share the name “KALDOR STEPHEN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE QUANTICEL RES INC

12 patents

US11084793B2Aug 10, 2021

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC3 citations84

US10207999B2Feb 19, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations84

US10023543B2Jul 17, 2018

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations84

US9776974B2Oct 3, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations84

US9771329B2Sep 26, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC6 citations84

US10316016B2Jun 11, 2019

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations83

US10047069B2Aug 14, 2018

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations83

US9828358B2Nov 28, 2017

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC5 citations83

US10654810B2May 19, 2020

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations73

US10494371B2Dec 3, 2019

Bromodomain inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10385051B2Aug 20, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations73

US9908885B2Mar 6, 2018

Bromodomain inhibitors

CELGENE QUANTICEL RES INC4 citations73

LILLY CO ELI

11 patents

US6204260B1Mar 20, 2001

Non-peptidyl vasopressin V1a antagonists

LILLY CO ELI62 citations94

US5792763AAug 11, 1998

Serotonin 5-HT1F agonists

LILLY CO ELI23 citations92

US5514778AMay 7, 1996

Anti-picornaviral agents

LILLY CO ELI20 citations92

US5508407AApr 16, 1996

Retroviral protease inhibitors

LILLY CO ELI27 citations92

US5434265AJul 18, 1995

Inhibitors of HIV protease

LILLY CO ELI22 citations92

US6060484AMay 9, 2000

Anti-viral method

LILLY CO ELI20 citations89

US6610680B1Aug 26, 2003

Non-peptidyl vasopressin V1A antagonists

LILLY CO ELI14 citations83

US5514802AMay 7, 1996

Intermediates for preparing HIV protease inhibitors

LILLY CO ELI16 citations82

US5491166AFeb 13, 1996

Inhibitors of HIV protease useful for the treatment of AIDS

LILLY CO ELI11 citations74

US6358994B1Mar 19, 2002

2-acylaminopropanamines as tachykinin receptor antagonists

LILLY CO ELI9 citations73

US5475136ADec 12, 1995

Inhibitors of HIV protease useful for the treatment of AIDS

LILLY CO ELI9 citations73

AGOURON PHARMA

8 patents

US5484926AJan 16, 1996

HIV protease inhibitors

AGOURON PHARMA158 citations99

US5827891AOct 27, 1998

HIV protease inhibtors

AGOURON PHARMA36 citations96

US5952343ASep 14, 1999

HIV protease inhibitors

AGOURON PHARMA8 citations82

US5846993ADec 8, 1998

HIV protease inhibitors

AGOURON PHARMA9 citations74

US6693199B2Feb 17, 2004

Method of making HIV protease inhibitors

AGOURON PHARMA2 citations73

US6525215B2Feb 25, 2003

HIV protease inhibitors

AGOURON PHARMA2 citations73

US6271235B1Aug 7, 2001

HIV protease inhibitors

AGOURON PHARMA5 citations73

US6162812ADec 19, 2000

Pharmaceutical compositions containing HIV protease inhibitors and methods of their use

AGOURON PHARMA2 citations73

KINNATE BIOPHARMA INC

5 patents

US10927111B2Feb 23, 2021

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC9 citations85

US11407737B2Aug 9, 2022

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC8 citations84

US11377431B2Jul 5, 2022

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC7 citations84

US11098031B1Aug 24, 2021

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC12 citations84

US11345681B1May 31, 2022

Inhibitors of fibroblast growth factor receptor kinases

KINNATE BIOPHARMA INC4 citations72

XINTHERA INC

4 patents

US11795173B1Oct 24, 2023

Substituted pyridines as PARP1 inhibitors

XINTHERA INC5 citations84

US11591331B2Feb 28, 2023

PARP1 inhibitors and uses thereof

XINTHERA INC6 citations74

US11685719B2Jun 27, 2023

Pyridinone MK2 inhibitors and uses thereof

XINTHERA INC3 citations72

US11680056B2Jun 20, 2023

MK2 inhibitors and uses thereof

XINTHERA INC3 citations72

QUANTICEL PHARMACEUTICALS INC

2 patents

US9255097B2Feb 9, 2016

Inhibitors of lysine specific demethylase-1

QUANTICEL PHARMACEUTICALS INC29 citations98

US9573930B2Feb 21, 2017

Inhibitors of lysine specific demethylase-1

QUANTICEL PHARMACEUTICALS INC15 citations93

TAKEDA PHARMACEUTICAL

2 patents

US7550590B2Jun 23, 2009

Dipeptidyl peptidase inhibitors

TAKEDA PHARMACEUTICAL20 citations92

US7470700B2Dec 30, 2008

Dipeptidyl peptidase inhibitors

TAKEDA PHARMACEUTICAL23 citations92

Quanticel Pharmaceuticals

1 patent

US9034900B2May 19, 2015

Bromodomain inhibitors

Quanticel Pharmaceuticals36 citations95

JONES BENJAMIN

1 patent

US8138168B1Mar 20, 2012

Renin inhibitors

JONES BENJAMIN23 citations88

FRONTHERA U S PHARMACEUTICALS LLC

1 patent

US11053219B2Jul 6, 2021

Substituted pyridines as TYK2 inhibitors

FRONTHERA U S PHARMACEUTICALS LLC9 citations83

TAKEDA SAN DIEGO INC

1 patent

US7642275B2Jan 5, 2010

Histone deacetylase inhibitors

TAKEDA SAN DIEGO INC12 citations83

CAO SHELDON X

1 patent

US8318727B2Nov 27, 2012

Polo-like kinase inhibitors

CAO SHELDON X13 citations77

PF MEDICAMENT

1 patent

US12312336B2May 27, 2025

Inhibitors of RAF kinases

PF MEDICAMENT2 citations74

Showing the top 50 of 92 patents by PatentIndex Score.